MSG Pharmaceuticals has welcomed a new guidance note from the Financial Conduct Authority (FCA) on its approach to assessing applications from cannabis-related companies for listing on the London Stock Exchange (LSE). The new guidance advises that overseas companies may be admitted to the Official List, provided they are satisfied the Proceeds of Crime Act 2002 (PoCA) does not apply and companies otherwise satisfy the criteria for listing. Also, MGC reported it’s UK advisors are confident the MGC Pharma business and operations fully comply with the new FCA listing approval requirements.

Mmp News Author, Medical Marijuana Program Connection, 09/20/2020 21:15:20

Open article: